Table 1.
Patient demographics of N=127 stage IIIA lung cancer patients by treatment group.
| Characteristic | Neoadjuvant therapy + surgery (n=33) | Chemoradiation alone (n=94) | P-value |
|---|---|---|---|
| Age, years (mean ±sd) | 60.1±11.1 | 67.9±10.7 | 0.001 |
| Gender | 0.84 | ||
| Male, n (%) | 18 (54.5%) | 54 (57.4%) | |
| Female, n (%) | 15 (45.5%) | 40 (42.6%) | |
| Histology* | N/A | ||
| Adenocarcinoma, n (%) | 16 (50%) | ||
| Squamous cell, n (%) | 11 (34.4%) | ||
| Adenosquamous, n (%) | 2 (6.3%) | ||
| Other, n (%) | 3 (9.4%) | ||
| Lymph Node ≥2.5 cm | 6 (18.2%) | 68 (72.3%) | <0.0002 |
*
Histology findings among n=32 lung cancer cases with a confirmed pathological diagnosis.